C. Levy

Caution With the Use of Lopinavir/Ritonavir in Severely Ill Patients for the Treatment of SARS-CoV-2: A Report of Severe Jaundice

P. Mathurin, J. Poissy, T. Duburcq, 2020, The American journal of gastroenterology.

Transcatheter aortic valve replacement (TAVR) as bridge therapy restoring eligibility for liver transplantation in cirrhotic patients

S. Truant, F. Pruvot, C. Delhaye, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Are Cirrhotic Patients Receiving Invasive Mechanical Ventilation at Risk of Abundant Microaspiration

J. Reignier, S. Nseir, E. Jaillette, 2022, Journal of clinical medicine.

Assessment of plasma endocan for the prediction of mortality in COVID-19 patients undergoing veno-venous ECMO: A pilot study

R. Favory, D. Mathieu, S. Nseir, 2022, Medicina Intensiva (English Edition).

Assessment of plasma endocan for the prediction of mortality in COVID-19 patients undergoing veno-venous ECMO: A pilot study

R. Favory, D. Mathieu, S. Nseir, 2022, Medicina Intensiva.

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial

Inge Christoffer Olsen, F. Lund-Johansen, Mariana H. S. Bernardo, 2023, Critical Care.

Management of renal replacement therapy among adults in French intensive care units: A bedside practice evaluation

P. Asfar, C. Vinsonneau, K. Klouche, 2023, Journal of intensive medicine.

Long-term outcome following liver transplantation of patients with ACLF grade 3.

A. Coilly, G. Pageaux, E. Boleslawski, 2024, Journal of hepatology.

Long-term outcome following liver transplantation for patients with acute on chronic liver failure grade 3 (ACLF-3): a retrospective matched-controlled study

D. Samuel, F. Saliba, E. Vibert, 2023, Journal of Hepatology.